Trefoil factor family 2 deficiency and immune response

Cellular and Molecular Life Sciences

Volumn 62, Issue 24, 2005, Pages 2947-2955

  Baus Loncar, M ^a,b   Kayademir, T ^b   Takaishi, S ^c   Wang, T ^c  

^a JOSIP JURAJ STROSSMAYER UNIVERSITY OF OSIJEK   (Croatia)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c College of Physicians and Surgeons ^*  (United States)

Author keywords

Gastrointestinal defense; Gene expression; Immune response; TFF2; TFF2 deficiency

Indexed keywords

ISOPROTEIN; LIPOPOLYSACCHARIDE; NITRIC OXIDE; TREFOIL PEPTIDE;

GASTROINTESTINAL DISEASE; GASTROINTESTINAL TRACT; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOREGULATION; INJURY; LEUKOCYTE; MONOCYTE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PROTEIN FAMILY; PROTEIN FUNCTION; REVIEW; TISSUE DISTRIBUTION; UNINDEXED SEQUENCE;

ANIMALS; GENE EXPRESSION REGULATION; GENES, MHC CLASS I; MICE; MICE, KNOCKOUT; MUCINS; MUSCLE PROTEINS; ORGAN SPECIFICITY; PEPTIDES;

LOTUS;

EID: 29344465645     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-005-5483-7     Document Type: Review

References (84)

1. Maury J., Bernadac A., Rigal A. and Maroux S. (1995) Expression and glycosylation of the filamentous brush border glycocalyx (FBBG) during rabbit enterocyte differentiation along the crypt-villus axis. J. Cell Sci. 108(7): 2705-2713
2. Ganz T. (2003) Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3: 710-720
3. Mowat A. M., Millington O. R. and Chirdo F. G. (2004) Anatomical and cellular basis of immunity and tolerance in the intestine. J. Pediatr. Gastroenterol. Nutr. 39 Suppl. 3: S723-S724
4. Medzhitov R. and Janeway C. Jr. (2000) Innate immunity. N. Engl. J. Med. 343: 338-344
5. Kindon H., Pothoulakis C., Thim L., Lynch-Devaney K. and Podolsky D. K. (1995) Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein. Gastroenterology 109: 516-523
6. Ayabe T., Satchell D. P., Wilson C. L., Parks W. C., Selsted M. E. and Ouellette A. J. (2000) Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat. Immunol. 1: 113-118
7. Zarember K. A. and Godowski P. J. (2002) Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products and cytokines. J. Immunol. 168: 554-561
8. Wittig B. M. and Zeitz M. (2003) The gut as an organ of immunology. Int. J. Colorectal Dis. 18: 181-187
9. Podolsky D. K. (1999) Mucosal immunity and inflammation. V. Innate mechanisms of mucosal defense and repair: the best offense is a good defense. Am. J. Physiol. 277: G495-G499
10. Taupin D. and Podolsky D. K. (2003) Trefoil factors: initiators of mucosal healing. Nat. Rev. Mol. Cell Biol. 4: 721-732
11. Thim L. (1989) A new family of growth factor-like peptides. 'Trefoil' disulphide loop structures as a common feature in breast cancer associated peptide (pS2), pancreatic spasmolytic polypeptide (PSP) and frog skin peptides (spasmolysins). FEBS Lett. 250: 85-90
12. Hoffmann W., Jagla W. and Wiede A. (2001) Molecular medicine of TFF-peptides: from gut to brain. Histol. Histopathol. 16: 319-334
13. Lemercinier X., Muskett F. W., Cheeseman B., McIntosh P. B., Thim L. and Carr M. D. (2001) High-resolution solution structure of human intestinal trefoil factor and functional insights from detailed structural comparisons with the other members of the trefoil family of mammalian cell motility factors. Biochemistry 40: 9552-9559
14. Westley B. R., Griffin S. M. and May F. E. (2005) Interaction between TFF1, a gastric tumor suppressor trefoil protein, and TFIZ1, a brichos domain-containing protein with homology to SP-C. Biochemistry 44: 7967-7975
15. Cook G. A., Yeomans N. D. and Giraud A. S. (1997) Temporal expression of trefoil peptides in the TGF-α knockout mouse after gastric ulceration. Am. J. Physiol. Gastrointest. Liver Physiol. 272: G1540-G1549
16. Dignass A., Lynch Devaney K., Kindon H., Thim L. and Podolsky D. K. (1994) Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway. J. Clin. Invest. 94: 376-383
17. Oertel M., Graness A., Thim L., Buhling E. Kalbacher H. and Hoffmann W. (2001) Trefoil factor family-peptides promote migration of human bronchial epithelial cells: synergistic effect with epidermal growth factor. Am. J. Respir. Cell Mol. Biol. 25: 418-424
18. Taupin D.R., Kinoshita K. and Podolsky D.K. (2000) Intestinal trefoil factor confers colonie epithelial resistance to apoptosis. Proc. Natl. Acad. Sci. USA 97: 799-804
19. Sands B. E. and Podolsky D. K. (1996) The trefoil peptide family. Annu. Rev. Physiol. 58: 253-273
20. Tebbutt N. C., Giraud A. S., Inglese M., Jenkins B., Waring P., Clay F. J. et al. (2002) Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat. Med. 8: 1089-1097
21. Blanchard C., Durual S., Estienne M., Bouzakri K., Heim M. H., Blin N. et al. (2004) IL-4 and IL-13 up-regulate intestinal trefoil factor expression: requirement for STAT6 and de novo protein synthesis. J. Immunol. 172: 3775-3783
22. Dossinger V., Kayademir T., Blin N. and Gott P. (2002) Downregulation of TFF expression in gastrointestinal cell lines by cytokines and nuclear factors. Cell Physiol. Biochem. 12: 197-206
23. Baus-Loncar M., Al azzeh E. D., Romanska H., Lalani E., Stamp G. W., Blin N. et al. (2004) Transcriptional control of TFF3 (intestinal trefoil factor) via promoter binding sites for the nuclear factor kappaB and C/EBPbeta. Peptides 25: 849-854
24. Cook G. A., Familari M. and Giraud A. S. (1999) The trefoil peptides TFF2 and TFF3 are expressed in rat lymphoid tissues and participate in the immune response. FEBS Lett. 456: 155-15925
25. Playford R. J., Marchbank T., Goodlad R. A., Chinery R. A., Poulsom R., Hanby A. M. et al. (1996) Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage. Proc. Natl. Acad. Sci. USA 93: 2137-2142
26. Marchbank T., Cox H. M., Goodlad R. A., Giraud A. S., Moss S. F., Poulsom R. et al. (2001) Effect of ectopic expression of rat trefoil factor family 3 (rTFF3, intestinal trefoil factor) in the jeunum of transgenic mice. J. Biol. Chem. 276 (26): 24088-24096
27. Lefebvre O., Chenard M. P., Masson R., Linares J., Dierich A., LeMeur,M. et al. (1996) Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 274: 259-262
28. Farrell J. J., Taupin D., Koh T. J., Chen D., Zhao C. M., Podolsky D. K. et al. (2002) TFF2/SP-deficient mice show decreased gastric proliferation, increased acid secretion and increased susceptibility to NSAID injury. J. Clin. Invest. 109: 193-204
29. Mashimo H., Wu D. C., Podolsky D. K. and Fishman M. C. (1996) Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 274: 262-265
30. Carvalho R., Kayademir T., Soares P., Canedo P., Sousa S., Oliveira C. et al. (2002) Loss of heterozygosity and promoter methylation, but not mutation, may underlie loss of TFF1 in gastric carcinoma. Lab. Invest. 82: 1319-1326
31. Taupin D. R., Kinoshita K. and Podolsky D. K. (2000) Intestinal trefoil factor confers colonie epithelial resistance to apoptosis. Proc. Natl. Acad. Sci. USA 97: 799-804
32. Baus-Loncar M., Schmid J., Lalani E. N., Rosewell I., Goodlad R. A., Stamp G. W. H. et al. (2005) Trefoil Factor 2 deficiency in murine digestive tract influences the immune system. Cell Physiol Biochem. 16: 31-42
33. McKenzie C., Thim L. and Parsons M. E. (2000) Topical and intravenous administration of trefoil factors protect the gastric mucosa from ethanol-induced injury in the rat. Aliment. Pharmacol. Ther. 14: 1033-1040
34. Babyatsky M. W., deBeaumont M., Thim L. and Podolsky D. K. (1996) Oral trefoil peptides protect against ethanol- and indomethacin-induced gastric injury in rats. Gastroenterology 110: 489-497
35. Jorgensen K. D., Diamant B., Jorgensen K. H. and Thim L. (1982) Pancreatic spasmolytic polypeptide (PSP): III. Pharmacology of a new porcine pancreatic polypeptide with spasmolytic and gastric acid secretion inhibitory effects. Regul. Pept. 3: 231-243
36. Konturek P. C., Brzozowski T., Konturek S. J., Elia G., Wright N., Sliwowski Z. et al. (1997) Role of spasmolytic polypeptide in healing of stress-induced gastric lesions in rats. Regul. Pept. 68: 71-79
37. Ouellette A. J. and Bevins C. L. (2001) Paneth cell defensins and innate immunity of the small bowel. Inflamm. Bowel. Dis. 7: 43-50
38. Oppenheim J. J., Biragyn A., Kwak L. W. and Yang D. (2003) Roles of antimicrobial peptides such as defensins in innate and adaptive immunity. Ann. Rheum. Dis. 62: 17-21
39. Lin P. W., Simon P. O. Jr., Gewirtz A. T., Neish A. S., Ouellette A. J., Madara J. L. et al. (2004) Paneth cell cryptdins act in vitro as apical paracrine regulators of the innate inflammatory response. J. Biol. Chem. 279: 19902-19907
40. Lencer W. I., Cheung G., Strohmeier G. R., Currie M. G., Ouellette A. J., Selsted M. E. et al. (1997) Induction of epithelial chloride secretion by channel-forming cryptdins 2 and 3. Proc. Natl. Acad. Sci. USA 94: 8585-8589
41. Davis B. A., Blanchard R. K., Lanningham-Foster L. and Cousins R. J. (1998) Structural characterization of the rat cysteine-rich intestinal protein gene and overexpression of this LIM-only protein in transgenic mice. DNA Cell Biol. 17: 1057-1064
42. Lanningham-Foster L., Green C. L., Langkamp-Henken B., Davis B. A., Nguyen K. T., Bender B. S. et al. (2002) Overexpression of CRIP in transgenic mice alters cytokine patterns and the immune response. Am. J. Physiol. Endocrin. Metabol. 282: E1197-E1203
43. Poulsen S. S., Thulesen J., Nexo E. and Thim L. (1998) Distribution and metabolism of intravenously administered trefoil factor 2/porcine spasmolytic polypeptide in the rat. Gut 43: 240-247
44. Poulsen S. S., Thulesen J., Hartmann B., Kissow H. L., Nexo E. and Thim L. (2003) Injected TFF1 and TFF3 bind to TFF2-immunoreactive cells in the gastrointestinal tract in rats. Regul. Pept. 115: 91-99
45. Sanchez-Pulido L., Devos D. and Valencia A. (2002) BRICHOS: a conserved domain in proteins associated with dementia, respiratory distress and cancer. Trends Biochem. Sci. 27: 329-332
46. Matsui M., Machida S., Itani-Yohda T. and Akatsuka T. (2002) Downregulation of the proteasome subunits, transporter and antigen presentation in hepatocellular carcinoma, and their restoration by interferon-gamma. J. Gastroenterol. Hepatol. 17: 897-907
47. Kohda K., Matsuda Y., Ishibashi T., Tanaka K. and Kasahara M. (1997) Structural analysis and chromosomal localization of the mouse Psmb5 gene coding for the constitutively expressed beta-type proteasome subunit. Immunogenetics 47: 77-87
48. Hallermalm K., Seki K., Wei C., Castelli C., Rivoltini L., Kiessling R. et al. (2001) Tumor necrosis factor-alpha induces coordinated changes in major histocompatibility class I presentation pathway, resulting in increased stability of class I complexes at the cell surface. Blood 98: 1108-1115
49. Lankat-Buttgereit B. and Tampe R. (2002) The transporter associated with antigen processing: function and implications in human diseases. Physiol. Rev. 82: 187-204
50. Rivett A. J. and Hearn A. R. (2004) Proteasome function in antigen presentation: immunoproteasome complexes, peptide production and interactions with viral proteins. Curr. Protein Pept. Sci. 5: 153-161
51. Heink S., Ludwig D., Kloetzel P. M. and Kruger E. (2005) IFN-{gamma}-induced immune adaptation of the proteasome system is an accelerated and transient response. Proc. Natl. Acad. Sci. USA 102(26): 9241-9246
52. Chen W., Norbury C. C., Cho Y., Yewdell J. W. and Bennink J. R. (2001) Immunoproteasomes shape immunodominance hierarchies of antiviral CD8(+) T cells at the levels of T cell repertoire and presentation of viral antigens. J. Exp. Med. 193: 1319-1326
53. Toes R. E., Nussbaum A. K., Degermann S., Schirle M., Emmerich N. P., Kraft M. et al. (2001) Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. J. Exp. Med. 194: 1-12
54. Ritz U., Momburg F., Pilch H., Huber C., Maeurer M. J. and Seliger B. (2001) Deficient expression of components of the MHC class I antigen processing machinery in human cervical carcinoma. Int. J. Oncol. 19: 1211-1220
55. Seliger B., Wollscheid U., Momburg F., Blankenstein T. and Huber C. (2001) Characterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells. Cancer Res. 61: 1095-1099
56. Ehrlich R. (1997) Modulation of antigen processing and presentation by persistent virus infections and in tumors. Hum. Immunol. 54:104-116
57. Vambutas A., Bonagura V. R. and Steinberg B. M. (2000) Altered expression of TAP-1 and major histocompatibility complex class I in laryngeal papillomatosis: correlation of TAP-1 with disease. Clin. Diagn. Lab. Immunol. 7: 79-85
58. Zeidler R., Eissner G., Meissner P., Uebel S., Tampe R., Lazis S. et al. (1997) Downregulation of TAP1 in B lymphocytes by cellular and Epstein-Barr virus-encoded interleukin-10. Blood 90: 2390-2397
59. Alimonti J., Zhang Q. J., Gabathuler R., Reid G., Chen S. S. and Jefferies W. A. (2000) TAP expression provides a general method for improving the recognition of malignant cells in vivo. Nat. Biotechnol. 18: 515-520
60. Zhang Q. J., Alimonti J., Chen S. S., Moise A., Tiong J. and Jefferies W. A. (2002) Over-expression of TAP's augments immune responses in normal mice. FASEB J. 16: A312
61. Doong H., Vrailas A. and Kohn E. C. (2002) What's in the 'BAG'? - A functional domain analysis of the BAG-family proteins. Cancer Lett. 188: 25-32
62. Ueda K., Kosako H., Fukui Y. and Hattori S. (2004) Proteomic identification of Bcl2-associated athanogene 2 as a novel MAP kinase-activated protein kinase 2 substrate. J. Biol. Chem. 279 (40): 41815-41821
63. Roth W., Grimmel C., Rieger L., Strik H., Takayama S., Krajewski S. et al. (2000) Bag-1 and Bcl-2 gene transfer in malignant glioma: modulation of cell cycle regulation and apoptosis. Brain Pathol. 10: 223-234
64. Takayama S. and Reed J. C. (2001) Molecular chaperone targeting and regulation by BAG family proteins. Nat. Cell Biol. 3: E237-E241
65. Nikolaidis N. M., Zimmermann N., King N. E., Mishra A., Pope S. M., Finkelman F. D. et al. (2003) Trefoil factor-2 is an allergen-induced gene regulated by Th2 cytokines and STAT6 in the lung. Am. J. Respir. Cell Mol. Biol. 29: 458-464
66. Alican I. and Kubes P. (1996) A critical role for nitric oxide in intestinal barrier function and dysfunction. Am. J. Physiol. 270: G225-G237
67. Wallace J. L. and Miller M. J. (2000) Nitric oxide in mucosal defense: a little goes a long way. Gastroenterology 119: 512-520
68. Beckman J. S., Beckman T. W., Chen J., Marshall P. A. and Freeman B. A. (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87: 1620-1624
69. Miampamba M. and Sharkey K. A. (1999) Temporal distribution of neuronal and inducible nitric oxide synthase and nitrotyrosine during colitis in rats. Neurogastroenterol. Motil. 11: 193-206
70. Noiri E., Peresleni T., Srivastava N., Weber P., Bahou W. F., Peunova N. et al. (1996) Nitric oxide is necessary for a switch from stationary to locomoting phenotype in epithelial cells. Am. J. Physiol. 270: C794-C802
71. Rubanyi G. M., Ho E. H., Cantor E. H., Lumma W. C. and Botelho L. H. (1991) Cytoprotective function of nitric oxide: inactivation of superoxide radicals produced by human leukocytes. Biochem. Biophys. Res. Commun. 181: 1392-1397
72. Stallmeyer B., Kampfer H., Kolb N., Pfeilschifter J. and Frank S. (1999) The function of nitric oxide in wound repair: inhibition of inducible nitric oxide-synthase severely impairs wound reepithelialization. J. Invest. Dermatol. 113: 1090-1098
73. Gookin J. L., Rhoads J. M. and Argenzio R. A. (2002) Inducible nitric oxide synthase mediates early epithelial repair of porcine ileum. Am. J. Physiol. Gastrointest. Liver Physiol. 283: G157-G168
74. Tan X. D., Liu Q. P., Hsueh W., Chen Y. H., Chang H. and Gonzalez-Crussi F. (1999) Intestinal trefoil factor binds to intestinal epithelial cells and induces nitric oxide production: priming and enhancing effects of mucin. Biochem. J. 338 (Pt. 3): 745-751
75. Giraud A. S., Pereira P. M., Thim L., Parker L. M. and Judd L. M. (2004) TFF-2 inhibits iNOS/NO in monocytes, and nitrated protein in healing colon after colitis. Peptides 25: 803-809
76. Tran C. P., Cook G. A., Yeomans N. D., Thim L. and Giraud A. S. (1999) Trefoil peptide TFF2 (spasmolytic polypeptide) potently accelerates healing and reduces inflammation in a rat model of colitis. Gut 44: 636-642
77. Soriano-Izquierdo A., Gironella M., Massaguer A., May F. E., Salas A., Sans M. et al. (2004) Trefoil peptide TFF2 treatment reduces VCAM-I expression and leukocyte recruitment in experimental intestinal inflammation. J. Leukoc. Biol. 75: 214-223
78. Liu J., Miwa T., Hilliard B., Chen Y., Lambris J. D., Wells A. D. et al. (2005) The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo. J. Exp. Med. 201: 567-577
79. Lin F., Fukuoka Y., Spicer A., Ohta R., Okada N., Harris C. L. et al. (2001) Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes. Exploitation of a Daf1 knock-out mouse and site-specific monoclonal antibodies. Immunology 104: 215-225
80. Moran P., Beasley H., Gorrell A., Martin E., Gribling P., Fuchs H. et al. (1992) Human recombinant soluble decay accelerating factor inhibits complement activation in vitro and in vivo. J. Immunol. 149: 1736-1743
81. Heeger P. S., Lalli P. N., Lin F., Valujskikh A., Liu J., Muqim N. et al. (2005) Decay-accelerating factor modulates induction of T cell immunity. J. Exp. Med. 201: 1523-1530
82. Makidono C., Mizuno M., Nasu J., Hiraoka S., Okada H., Yamamoto K. et al. (2004) Increased serum concentrations and surface expression on peripheral white blood cells of decay-accelerating factor (CD55) in patients with active ulcerative colitis. J. Lab Clin. Med. 143: 152-158
83. Berstad A. E. and Brandtzaeg P. (1998) Expression of cell membrane complement regulatory glycoproteins along the normal and diseased human gastrointestinal tract. Gut 42: 522-529
84. Barrington R., Zhang M., Fischer M. and Carroll M. C. (2001) The role of complement in inflammation and adaptive immunity. Immunol. Rev. 180: 5-15